drugset / Trial / NCT00562250

Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects

NCT00562250

Phase 1 Completed 11 enrolled AstraZeneca Bristol-Myers Squibb · collab
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of the study is to determine the effect of glimepiride on dapagliflozin and the effect of dapagliflozin on glimepiride in healthy volunteers. In addition, the safety and tolerability of dapagliflozin with be assessed alone and while taking glimepiride

Timeline

Start
2008-05
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapagliflozin Small molecule 20 mg Oral
Comparator Glimepiride Small molecule 4 mg Oral